Ashktorab Hassan, Nouraie Mehdi, Hosseinkhah Fatemeh, Lee Edward, Rotimi Charles, Smoot Duane
Department of Medicine and Cancer Center, Howard University, College of Medicine, Washington, DC 20060, USA.
Dig Dis Sci. 2009 Sep;54(9):1985-90. doi: 10.1007/s10620-009-0866-5. Epub 2009 Jun 25.
African-Americans (AA) have the highest rate of colorectal cancer (CRC) incidence and mortality in the US. CRC in AA is more advanced and right-sided. Although screening has been shown to reduce mortality from CRC in the general US population, AA continue to experience a disproportionately higher CRC death compared to other ethnic groups. This study aimed at assessing the trend of CRC in AA, focusing on the changing pattern of in situ tumors in this ethnic group and how observed trends may guide current and future preventive and treatment strategies.
All pathologic reports from 1959 to 2006 in Howard University Hospital (n = 150,000) were reviewed manually. The pathology reports showing colorectal cancer were carefully reviewed and selected by a GI pathologist. Intraepithelial or intramucosal carcinomas were diagnosed as in situ carcinoma. Reviewed pathological information were entered into Microsoft Excel and checked for duplication and missing data. Differences in situ and advanced cancer by sex, histology, location, and years of diagnosis were assessed by Chi-square test.
A total of 1,753 CRC cases were diagnosed in this period. About 56% of the cases were female and 51% of the tumors were left-sided. Mean (SD) age was 66 (13) years. The frequency of in situ tumor was 5.8% in this period. There was no statistically significant difference between in situ and advance tumor by age, sex, and tumor location. The rate of in situ tumor peaked in the 1990s at 8.5% (P = 0.0001). We observed a decade-to-decade increasing rate of right-sided tumors, which started at 36% in the period 1959-1970 and peaked in the period of 2001-2006 at 60% (P = 0.0001).
The recent increasing number of advanced and right-sided tumor in our study is concordant with SEER data and has great importance in developing CRC prevention and treatment strategies for AA population.
非裔美国人(AA)在美国的结直肠癌(CRC)发病率和死亡率最高。非裔美国人的结直肠癌病情更严重且多发生在右侧。尽管筛查已被证明可降低美国普通人群的结直肠癌死亡率,但与其他种族群体相比,非裔美国人的结直肠癌死亡比例仍然过高。本研究旨在评估非裔美国人结直肠癌的发病趋势,重点关注该种族原位肿瘤的变化模式以及观察到的趋势如何指导当前和未来的预防及治疗策略。
人工查阅了霍华德大学医院1959年至2006年的所有病理报告(n = 150,000)。由胃肠病理学家仔细审查并挑选出显示结直肠癌的病理报告。上皮内或黏膜内癌被诊断为原位癌。将审查后的病理信息录入Microsoft Excel,并检查数据重复和缺失情况。通过卡方检验评估原位癌和进展期癌在性别、组织学、位置及诊断年份方面的差异。
在此期间共诊断出1753例结直肠癌病例。约56%的病例为女性,51%的肿瘤位于左侧。平均(标准差)年龄为66(13)岁。在此期间原位肿瘤的发生率为5.8%。原位癌和进展期癌在年龄、性别及肿瘤位置方面无统计学显著差异。原位肿瘤发生率在20世纪90年代达到峰值,为8.5%(P = 0.0001)。我们观察到右侧肿瘤的发生率每十年呈上升趋势,从1959 - 1970年期间的36%开始,在2001 - 2006年期间达到峰值,为60%(P = 0.0001)。
我们研究中近期进展期和右侧肿瘤数量的增加与监测、流行病学和最终结果(SEER)数据一致,对制定非裔美国人群的结直肠癌预防和治疗策略具有重要意义。